Patent · US Active

Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof

US8946384B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA · CN

Inventors

Hui Wang · Lo Wu, CN
Tao Li · San Diego, US
Qin Wang · Plainsboro, US
Wei Tu · Beijing, CN
Xiaojun Hou · Yuncheng, CN
Yuenan Liu · Shenyang, CN
Jing Shi · Beijing, CN
Kun Cai · 红钢城街道, CN

Key dates

Filing date	Sep 9, 2011
Grant date	Feb 3, 2015
Priority date	—
Expiry date	Sep 9, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a polypeptide TF1 for inhibiting type-2 Shiga-toxin activity, an encoding gene for the same and use thereof. The present polypeptide is named TF1 (also known as P1); its amino acid sequence is shown in SEQ ID NO: 1 in the sequence list. The polypeptide P1 can be prepared into medicine for preventing and/or treating diseases caused by type-2 Shiga toxin or the pathogens which produce type-2 Shiga toxin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.